Brought to you by 
Charles River buys Argenta and BioFocus from Galapagos for €129mm plus earn-outs
10 Sep 2020
Executive Summary
Charles River Laboratories International Inc. acquired Galapagos NV’s drug discovery service providers Argenta Discovery Ltd. and BioFocus DPI for a total of €129mm ($179mm) in cash up front, plus up to another €5mm in performance-based earn-outs.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
- Services
-
Biotechnology
-
Drug Discovery Tools
- ADMET
- Bioinformatics
-
Molecular Diversity
- Natural Products
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Contract
- Includes Earnout
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Charles River buys Argenta and BioFocus from Galapagos for €129mm plus earn-outs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice